Meg Jardine's Publications

About Meg Jardine's Publications

Honorary Professorial Fellow, The George Institute for Global Health
  • Associate Professor, Faculty of Medicine, UNSW Sydney

  • FACTORS AFFECTING HOSPITAL INPATIENT BLOOD PRESSURE MEASUREMENT AS RANKED BY A DELPHI SURVEY

    Journal of Hypertension Date published:

  • AN AUDIT OF INPATIENT BLOOD PRESSURE MEASUREMENT FOCUSING ON ACCURATE TECHNIQUE

    Journal of Hypertension Date published:

  • Clinical Implications of Slope of GFR in Clinical Trials of CKD Progression

    Clinical Journal of the American Society of Nephrology Date published:

  • Glomerular disease registry and biobank: design and baseline results

    Internal Medicine Journal Date published:

  • Safety and Effectiveness of Apixaban versus Warfarin by Kidney Function in Atrial Fibrillation

    Kidney360 Date published:

  • A review of the safety of sodium-glucose co-transporter-2 inhibitors

    Diabetes, Obesity and Metabolism Date published:

  • Aligning kidney function assessment in patients with cancer to global practices in internal medicine

    eClinicalMedicine Date published:

  • The Efficacy and Safety of Canagliflozin by Frailty Status in Participants of the CANVAS and CREDENCE Trials

    Journal of the American Geriatrics Society Date published:

  • Waiver of informed consent in clinical research: a summary of contemporary guidelines and a resource for researchers

    BMJ Open Date published:

  • The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial

    Kidney International Date published:

  • Chronic kidney disease-mineral and bone disorder: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Kidney International Date published:

  • Effects of SGLT2 inhibition on insulin use in CKD and type 2 diabetes: insights from the CREDENCE trial

    Nephrology Dialysis Transplantation Date published:

  • Atrasentan in Patients with IgA Nephropathy

    New England Journal of Medicine Date published:

  • Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: A participant-level pooled analysis of the CANVAS and CREDENCE trials

    European Journal of Heart Failure Date published:

  • Cardiovascular, kidney and safety outcomes with canagliflozin in older adults: A combined analysis from the CANVAS Program and CREDENCE trial

    Diabetes, Obesity and Metabolism Date published:

  • Glomerular Disease Registry and Biobank: Baseline and Follow-Up Results

    Date published: